MRK vs ZTS
By Alex · Tickerpine
Merck & Co., Inc. vs Zoetis Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | MRK | ZTS |
|---|---|---|
| Price | $128.66 | $76.09 |
| Market cap | $317.77B | $31.90B |
| P/E ratio | 36.2 | 12.5 |
| ROE | 18.94% | 67.75% |
| Profit margin | 13.59% | 28.04% |
| Revenue growth | 4.90% | 2.90% |
| Dividend yield | 2.64% | 2.79% |
| Beta | 0.22 | 0.74 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
MRK vs ZTS in plain English
- MRK is the bigger company — about 10.0× the market cap of ZTS.
- ZTS is cheaper on earnings (P/E 12.5 vs 36.2).
- ZTS earns a higher return on equity (68% vs 19%).
- MRK is growing revenue faster (5% vs 3%).
- ZTS has the higher dividend yield (2.79% vs 2.64%).
How would $1,000 have done in each?
MRK return calculator
See what $1,000 in Merck & Co., Inc. would be worth today.
ZTS return calculator
See what $1,000 in Zoetis Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.